Please login to the form below

Not currently logged in

product withdrawal

This page shows the latest product withdrawal news and features for those working in and with pharma, biotech and healthcare.

Fertility drugs drive healthcare growth at Merck KGaA

Fertility drugs drive healthcare growth at Merck KGaA

The company put the performance in the quarter down to the withdrawal of a rival product - Ferring's Bravelle - from the US market last year because of quality issues, as well

Latest news

  • Teva suspends migraine patch on burn reports Teva suspends migraine patch on burn reports

    In addition to the suspension from sale, Teva is also carrying out a pharmacy level recall of Zecuity and patients are recommended to stop using the product straight away.

  • European pharmacovigilance changes approved European pharmacovigilance changes approved

    Pharma companies will be forced to be more transparent about the reasons for the withdrawal of a medicinal product from the market, so that withdrawal for safety reasons can be easily ... No product will fall through the net and escape scrutiny where

  • EudraVigilance Medicinal Product Dictionary requirements

    year EudraVigilance Medicinal Product Dictionary (EVMPD) data for every pharmaceutical product authorised in the EU. ... This includes inspection and even, potentially, the ultimate sanction of product withdrawal.

  • Vioxx 'risks can be immediate'

    its global withdrawal of the product (September 2004) when the cardiovascular side effects became apparent and supported by scientific evidence.

  • Communicable risk

    product for which there is a reasonable possibility that the product caused a response. ... to take urgent measures (product withdrawal from the market), and assessment of product risk via life cycle management.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    On 13 July the UK government put forward the European Union (Withdrawal) Bill by which the Government hopes to convert the entire body of EU law into British law. ... on certification of clinical trials, conformity with good manufacturing practices,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Real world project management

    The ex-trial patients were allowed to continue access free of charge until the product was commercially available in their country. ... In contrast to this is a programme we are managing to support the global withdrawal of an oncology product.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...